BGI Genomics Co (300676.SZ) Stock Price
BGI Genomics Co Price
Over the last 13 years BGI Genomics Co grew revenue by 12.6% annually, reaching 3.71 B CNY. Earnings per share have grown at 1.2% per year over the last 11 years. For BGI Genomics Co, the net margin of -16.6% is down versus 21.6% a few years ago. At today's price the dividend yield works out to roughly 0.23%. The consensus 12-month price target for BGI Genomics Co is 58.87 CNY, about 35.4% above where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.
BGI Genomics Co stock price
BGI Genomics Co business model & stock analysis
Frequently asked questions about BGI Genomics Co
Analysts currently set an average price target of 58.87 CNY for the BGI Genomics Co stock (median: 58.87 CNY), implying +35.4 % versus the latest price. The consensus is based on 5 analyst ratings.
5 analysts currently rate the BGI Genomics Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect BGI Genomics Co to generate revenue of 3.96 B CNY and earnings per share of 0.27 CNY.
Converted at the current exchange rate, the BGI Genomics Co share trades at 5.79 EUR (43.48 CNY).
The BGI Genomics Co share (300676.SZ) is listed on 1 stock exchanges, including: Shenzhen (300676.SZ).
The expected revenue of BGI Genomics Co is 3.96 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of BGI Genomics Co is 111.34 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of BGI Genomics Co is currently 162.57. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the BGI Genomics Co stock.
The price-to-sales ratio (P/S) of BGI Genomics Co is currently 4.57. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the BGI Genomics Co stock.
The Eulerpool Quality Score for BGI Genomics Co is 1/10.
The ISIN of BGI Genomics Co is CNE100003449. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of BGI Genomics Co is 300676.SZ. The ticker symbol is used to trade BGI Genomics Co shares on the stock exchange.
BGI Genomics Co stock
BGI Genomics Co Peer Group
BGI Genomics Co Ticker
BGI Genomics Co FIGI
All fundamentals and in-depth analysis of BGI Genomics Co
Our stock analysis for BGI Genomics Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BGI Genomics Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.